Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction

Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Blood samples from 249 co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arteriosclerosis, thrombosis, and vascular biology Jg. 28; H. 5; S. 954
Hauptverfasser: Zeller, Marianne, Korandji, Claudia, Guilland, Jean-Claude, Sicard, Pierre, Vergely, Catherine, Lorgis, Luc, Beer, Jean-Claude, Duvillard, Laurence, Lagrost, Anne-Cécile, Moreau, Daniel, Gambert, Philippe, Cottin, Yves, Rochette, Luc
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.05.2008
Schlagworte:
Aged
Aged, 80 and over
Arginine - analogs & derivatives
Arginine - blood
Biomarkers - blood
Cohort Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - mortality
Predictive Value of Tests
Prognosis
Prospective Studies
Regression Analysis
ISSN:1524-4636, 1524-4636
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Blood samples from 249 consecutive patients hospitalized for acute MI <24 hours were taken on admission. Serum levels of ADMA and its stereoisomer, symmetrical dimethylarginine (SDMA), were determined using high-performance liquid chromatography. The independent predictors of ADMA were glomerular filtration rate, female sex, and SDMA (R(2)=0. 25). Baseline ADMA levels were higher in patients who had died than in patients who were alive at 1 year follow-up (1.23 [0.98 to 1.56] versus 0.95 [0.77 to 1.20] micromol/L, P<0.001). By Cox multivariate analysis, the higher tertile of ADMA (median [interquartile range]: 1.45 [1.24 to 1.70] micromol/L) was a predictor for mortality (Hazard Ratio [95% CI], 4.83 [1.59 to 14.71]), when compared to lower tertiles, even when adjusted for potential confounders, such as acute therapy, biological, and clinical factors. Our study suggests that the baseline ADMA level has a strong prognostic value for mortality after MI, beyond traditional risk factors and biomarkers.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1524-4636
1524-4636
DOI:10.1161/ATVBAHA.108.162768